A rationally designed antimicrobial peptide from structural and functional insights of Clostridioides difficile translation initiation factor 1.|https://dx.doi.org/10.1128/spectrum.02773-23
Primary clostridium difficile infection in patients with ulcerative colitis: Case report and literature review.|https://dx.doi.org/10.1097/MD.0000000000036693
Current perspectives on fecal microbiota transplantation in inflammatory bowel disease.|https://dx.doi.org/10.1007/s12664-023-01516-8
The burden of Clostridioides difficile infections in South-East Asia and the Western Pacific: A narrative review.|https://dx.doi.org/10.1016/j.anaerobe.2024.102821
The management of Clostridioides difficile infection: from empirism to evidence.|https://dx.doi.org/10.15386/mpr-2622
A Systematic Literature Review on Risk Factors for and Timing of Clostridioides difficile Infection in the United States.|https://dx.doi.org/10.1007/s40121-024-00919-0
Molecular docking, dynamics and in vitro analysis of multi-target inhibitors for Clostridioides difficile.|https://dx.doi.org/10.6026/973206300200039
Clostridioides difficile -mucus interactions encompass shifts in gene expression, metabolism, and biofilm formation.|https://dx.doi.org/10.1101/2024.02.01.578425
Rapid Isothermal Detection of Pathogenic Clostridioides difficile Using Recombinase Polymerase Amplification.|https://dx.doi.org/10.1021/acs.analchem.3c02985
Pharmacomicrobiomics: Immunosuppressive Drugs and Microbiome Interactions in Transplantation.|https://dx.doi.org/10.1097/TP.0000000000004926
Estimating excess mortality and economic burden of Clostridioides difficile infections and recurrences during 2015-2019: The RECUR England study.|https://dx.doi.org/10.1016/j.ijid.2024.02.010
Metagenomic, metabolomic, and lipidomic shifts associated with fecal microbiota transplantation for recurrent Clostridioides difficile infection.|https://dx.doi.org/10.1101/2024.02.07.579219
Identification of Clostridioides difficile mutants with increased daptomycin resistance.|https://dx.doi.org/10.1128/jb.00368-23
Microbiota-Based Live Biotherapeutic Products for Clostridioides Difficile Infection- The Devil is in the Details.|https://dx.doi.org/10.2147/IDR.S419243
Assessment of Knowledge and Practice of Healthcare Providers in Saudi Arabia Regarding Clostridioides difficile Infection Diagnosis and Management: A Cross-Sectional Questionnaire-Based Study.|https://dx.doi.org/10.2147/IDR.S450281
Reduced Vancomycin Susceptibility in Clostridioides difficile is Associated with Lower Rates of Initial Cure and Sustained Clinical Response.|https://dx.doi.org/10.1093/cid/ciae087
Clostridioides difficile Infection: Diagnosis and Treatment Challenges.|https://dx.doi.org/10.3390/pathogens13020118
Faecal microbiota transplantation in children: A systematic review.|https://dx.doi.org/10.1111/apa.17167
AGA Clinical Practice Guideline on Fecal Microbiota-Based Therapies for Select Gastrointestinal Diseases.|https://dx.doi.org/10.1053/j.gastro.2024.01.008
Urinary Tract Infection Prevention and Treatment.|https://dx.doi.org/10.1016/j.semnephrol.2023.151468
Clostridioides difficile recurrence in individuals with and without cancer: a Swedish population-based cohort study.|https://dx.doi.org/10.1007/s15010-024-02193-1
RelQ-mediated alarmone signaling regulates growth, sporulation, and stress-induced biofilm formation in Clostridioides difficile.|https://dx.doi.org/10.1101/2024.02.14.580318
Long-term beneficial effect of faecal microbiota transplantation on colonisation of multidrug-resistant bacteria and resistome abundance in patients with recurrent Clostridioides difficile infection.|https://dx.doi.org/10.1186/s13073-024-01306-7
SER-109 (VOWST(â„¢)): A Review in the Prevention of Recurrent Clostridioides difficile Infection.|https://dx.doi.org/10.1007/s40265-024-02006-7
Recurrence of Clostridioides difficile infection and mortality in older inpatients.|https://dx.doi.org/10.1007/s41999-024-00942-x
Protective effects of fecal microbiota transplantation against ischemic stroke and other neurological disorders: an update.|https://dx.doi.org/10.3389/fimmu.2024.1324018
